Regulation of TGF-β and Cellular Signaling Pathways By SCARB2

Target Name: SCARB2

NCBI ID: G950

SCARB2

Regulation of TGF-β and Cellular Signaling Pathways By SCARB2

SCARB2 (Lysosomal Integral Membrane Protein II) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and muscle. It is a member of theScar protein family, which is known for their role in intracellular signaling and cellular signaling pathways.

SCARB2 is a 21-kDa protein that is expressed in the brain, heart, liver, and muscle. It is a key protein that is involved in the regulation of cellular signaling pathways, including the TGF-β pathway. TGF-β is a well -known developmental signaling pathway that is involved in the development, maintenance, and regression of tissues throughout the body.

One of the functions of SCARB2 is to regulate the activity of the TGF-β signaling pathway. This is done by interacting with and inhibiting the activity of the transcription factor Smad2. Smad2 is a key component of the TGF-β pathway, and it plays a role in regulating the activity of various cellular signaling pathways.

In addition to its role in regulating TGF-β signaling, SCARB2 is also involved in the regulation of cellular signaling pathways that are important for the development and maintenance of tissues. For example, SCARB2 has been shown to be involved in the regulation of cell adhesion. , as well as the regulation of the cytoskeleton.

SCARB2 is also involved in the regulation of cellular signaling pathways that are important for the development and maintenance of tissues. For example, SCARB2 has been shown to be involved in the regulation of cell adhesion, as well as the regulation of the cytoskeleton.

In addition to its role in regulating TGF-β and other signaling pathways, SCARB2 is also involved in the regulation of cellular signaling pathways that are important for the development and maintenance of tissues. For example, SCARB2 has been shown to be involved in the regulation of cell adhesion, as well as the regulation of the cytoskeleton.

SCARB2 is also a potential drug target in the development of various diseases. For example, SCARB2 has been shown to be involved in the regulation of cellular signaling pathways that are important for the development and maintenance of tissues, which makes it a potential target for the development of diseases such as cancer, neurodegenerative diseases, and cardiovascular diseases.

In conclusion, SCARB2 is a protein that is involved in the regulation of cellular signaling pathways that are important for the development and maintenance of tissues. It is a key protein that is involved in the regulation of TGF-β signaling pathway, as well as the regulation of other cellular signaling pathways. In addition to its role in regulating cellular signaling pathways, SCARB2 is also involved in the regulation of cell adhesion and the cytoskeleton. As a result, SCARB2 is a potential drug target for the development of various diseases. Further research is needed to fully understand the role of SCARB2 in cellular signaling pathways and its potential as a drug target.

Protein Name: Scavenger Receptor Class B Member 2

Functions: Acts as a lysosomal receptor for glucosylceramidase (GBA1) targeting

The "SCARB2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCARB2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets